Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-23

Clinical Trial Update: Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of desmopressin for treating nocturia in adult women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desmopressin (Desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 2 | Status: COMPLETED